Release
📈 Stocks
SpyGlass Pharma Acquires AVS for $13 Million to Scale IOL Manufacturing
(45 days ago)
SpyGlass Pharma strengthens its supply chain by acquiring AVS from Santen Pharmaceutical for $13 million, securing essential manufacturing capacity for its Phase…